Ketoacidosis associated with type 2 sodium-glucose cotransporter inhibitors (SGLT2i) in patients aged 65 and older: Evidence from the French national pharmacovigilance database.

65歲及以上患者使用第二型鈉-葡萄糖共轉運蛋白抑制劑（SGLT2i）相關的酮酸中毒：來自法國國家藥物警戒資料庫的證據